SCHEMBL4428033

SCHEMBL4428033

CC(=O)C(Cl)C(Cl)c1cccc([N+](=O)[O-])c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
ACP3 P15309 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
TSHR P16473 4/20 0.47
LMNA P02545 2/20 0.47
HTT P42858 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
MEN1 O00255 1/20 0.47
HPGD P15428 1/20 0.47
KMT2A Q03164 1/20 0.47
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
GLO1 Q04760 1/20 0.46
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A4 P31645 1/20 0.45
SLC6A3 Q01959 1/20 0.45
TP53 P04637 1/20 0.45
ACHE P22303 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6627469 0.84 ALDH1A1 (0.54) ALDH1A1ACP3SMN1; SMN2TSHRLMNA
SCHEMBL7271927 0.81 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2TSHRLMNAHTT
SCHEMBL11707796 0.80 TSHR (0.57) ALDH1A1ACP3SMN1; SMN2TSHRLMNA
SCHEMBL12395373 0.80 ALDH1A1 (0.56) ALDH1A1ACP3SMN1; SMN2TSHRLMNA
SCHEMBL49507 0.78 ALDH1A1 (0.54) ALDH1A1ACP3SMN1; SMN2TSHRLMNA
SCHEMBL3384133 0.77 TSHR (0.57) ALDH1A1ACP3SMN1; SMN2TSHRLMNA
SCHEMBL11802999 0.77 TSHR (0.57) ALDH1A1ACP3SMN1; SMN2TSHRLMNA
SCHEMBL3642758 0.77 TSHR (0.61) ALDH1A1ACP3SMN1; SMN2TSHRLMNA
SCHEMBL7126589 0.76 ALDH1A1 (0.56) ALDH1A1ACP3SMN1; SMN2TSHRLMNA
SCHEMBL5035510 0.76 ACP3 (0.55) ALDH1A1ACP3SMN1; SMN2TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114940-A1 AZA-ISOINDOLONES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS - 613 AstraZeneca AB (SE) 2009-11-11 EP disclosed
WO-2008100715-A1 AZA-ISOINDOLONES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS - 613 ASTRAZENECA AB (SE) 2008-08-21 WO disclosed